Show simple item record

Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

dc.contributor.authorBourke, Len_US
dc.contributor.authorKirkbride, Pen_US
dc.contributor.authorHooper, Ren_US
dc.contributor.authorRosario, AJen_US
dc.contributor.authorChico, TJAen_US
dc.contributor.authorRosario, DJen_US
dc.date.accessioned2016-11-30T11:55:55Z
dc.date.available2012-09-20en_US
dc.date.issued2013-01-15en_US
dc.date.submitted2016-03-01T18:35:46.371Z
dc.identifier.issn0007-0920en_US
dc.identifier.other10.1038/bjc.2012.523
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/18031
dc.format.extent9 - 13en_US
dc.language.isoenen_US
dc.relation.ispartofBRITISH JOURNAL OF CANCERen_US
dc.rightsCreative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
dc.subjectprostate canceren_US
dc.subjectandrogen deprivationen_US
dc.subjectcost-effectivenessen_US
dc.subjectcardiovascular risken_US
dc.titleEndocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?en_US
dc.typeArticle
dc.rights.holder& 2013 Cancer Research UK
dc.identifier.doi10.1038/bjc.2012.523en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000314800600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume108en_US


Files in this item

Thumbnail
Name:
Bourke et a 2013 Endocrine therapy ...
Size:
243.7Kb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record